{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:12:35Z","timestamp":1793711555484,"version":"4.6.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Sleep Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s44470-025-00038-8","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:21:02Z","timestamp":1776100862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Combination treatment for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3288-1864","authenticated-orcid":false,"given":"Daniel J.","family":"Buysse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5084-9331","authenticated-orcid":false,"given":"J. Todd","family":"Arnedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9292-879X","authenticated-orcid":false,"given":"Luis","family":"Buenaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9674-6563","authenticated-orcid":false,"given":"Judy L.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9584-6161","authenticated-orcid":false,"given":"Julio","family":"Fernandez-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0900-043X","authenticated-orcid":false,"given":"Salma I.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1038-8961","authenticated-orcid":false,"given":"Eric S.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4688-3211","authenticated-orcid":false,"given":"Yngve","family":"Falck-Ytter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4800-2366","authenticated-orcid":false,"given":"Suzanne","family":"Hyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1794-5073","authenticated-orcid":false,"given":"Uzma","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3393-8586","authenticated-orcid":false,"given":"Mandeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2858-7742","authenticated-orcid":false,"given":"Emerson M.","family":"Wickwire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"38_CR1","doi-asserted-by":"publisher","unstructured":"Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307\u201349. https:\/\/doi.org\/10.5664\/jcsm.6470.","DOI":"10.5664\/jcsm.6470"},{"issue":"2","key":"38_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5664\/jcsm.8986","volume":"17","author":"JD Edinger","year":"2021","unstructured":"Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(2):255\u201362. https:\/\/doi.org\/10.5664\/jcsm.8986.","journal-title":"J Clin Sleep Med"},{"key":"38_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.70089","author":"A van Straten","year":"2025","unstructured":"van Straten A, Weinreich KJ, F\u00e1bi\u00e1n B, et al. The prevalence of insomnia disorder in the general population: a meta-analysis. J Sleep Res. 2025. https:\/\/doi.org\/10.1111\/jsr.70089.","journal-title":"J Sleep Res"},{"key":"38_CR4","volume-title":"International classification of sleep disorders","author":"American Academy of Sleep Medicine","year":"2023","unstructured":"American Academy of Sleep Medicine. International classification of sleep disorders. 3rd ed, text revision. Darien, IL: American Academy of Sleep Medicine; 2023.","edition":"3rd ed, text re"},{"issue":"3","key":"38_CR5","first-page":"229","volume":"51","author":"DA Katz","year":"2002","unstructured":"Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J Fam Pract. 2002;51(3):229\u201335.","journal-title":"J Fam Pract"},{"issue":"3","key":"38_CR6","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.ijcard.2014.07.284","volume":"176","author":"M Li","year":"2014","unstructured":"Li M, Zhang XW, Hou WS, Tang ZY. Insomnia and risk of cardiovascular disease: a meta-analysis of cohort studies. Int J Cardiol. 2014;176(3):1044\u20137.\u00a0https:\/\/doi.org\/10.1016\/j.ijcard.2014.07.284.","journal-title":"Int J Cardiol"},{"key":"38_CR7","doi-asserted-by":"publisher","unstructured":"Bertisch SM, Pollock BD, Mittleman MA et al. Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: sleep heart health study. Sleep. 2018;41(6):047.\u00a0https:\/\/doi.org\/10.1093\/sleep\/zsy047.","DOI":"10.1093\/sleep\/zsy047"},{"key":"38_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2024.101914","volume":"75","author":"Y Dai","year":"2024","unstructured":"Dai Y, Vgontzas AN, Chen L, et al. A meta-analysis of the association between insomnia with objective short sleep duration and risk of hypertension. Sleep Med Rev. 2024;75:101914.\u00a0https:\/\/doi.org\/10.1016\/j.smrv.2024.101914.","journal-title":"Sleep Med Rev"},{"key":"38_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.smrv.2015.10.002","volume":"30","author":"T Anothaisintawee","year":"2016","unstructured":"Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A. Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis. Sleep Med Rev. 2016;30:11\u201324.https:\/\/doi.org\/10.1016\/j.smrv.2015.10.002.","journal-title":"Sleep Med Rev"},{"key":"38_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0006-3223(95)00188-3","volume":"39","author":"N Breslau","year":"1996","unstructured":"Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39:411\u201318.\u00a0https:\/\/doi.org\/10.1016\/0006-3223(95)00188-3.","journal-title":"Biol Psychiatry"},{"issue":"1\u20133","key":"38_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jad.2011.01.011","volume":"135","author":"C Baglioni","year":"2011","unstructured":"Baglioni C, Battagliese G, Feige B, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135(1\u20133):10\u20139.\u00a0https:\/\/doi.org\/10.1016\/j.jad.2011.01.011.","journal-title":"J Affect Disord"},{"key":"38_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.smrv.2018.10.006","volume":"43","author":"E Hertenstein","year":"2019","unstructured":"Hertenstein E, Feige B, Gmeiner T, et al. Insomnia as a predictor of mental disorders: a systematic review and meta-analysis. Sleep Med Rev. 2019;43:96\u2013105.\u00a0https:\/\/doi.org\/10.1016\/j.smrv.2018.10.006.","journal-title":"Sleep Med Rev"},{"key":"38_CR13","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association DSM-5 Task Force. Diagnostic and statistical manual of mental disorders: DSM-5\u2122 (5th ed.). American Psychiatric Publishing, Inc. 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"4","key":"38_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.\u00a0https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"38_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.5664\/jcsm.5412","volume":"12","author":"TI Morgenthaler","year":"2016","unstructured":"Morgenthaler TI, Deriy L, Heald JL, Thomas SM. The evolution of the AASM clinical practice guidelines: another step forward. J Clin Sleep Med. 2016;12(1):129\u201335.\u00a0https:\/\/doi.org\/10.5664\/jcsm.5412.","journal-title":"J Clin Sleep Med"},{"key":"38_CR16","doi-asserted-by":"publisher","unstructured":"Buysse DJ, Arnedt JT, Buenaver L, et al. Combination treatment for chronic insomnia disorder in adults: an American Academy of Sleep\u00a0Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2026;22(1).\u00a0https:\/\/doi.org\/10.1007\/s44470-025-00039-7.","DOI":"10.1007\/s44470-025-00039-7"},{"issue":"2","key":"38_CR17","doi-asserted-by":"publisher","first-page":"123","DOI":"10.7326\/M15-2175","volume":"165","author":"A Qaseem","year":"2016","unstructured":"Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians management of chronic insomnia disorder in adults. Ann Intern Med. 2016;165(2):123\u201333.\u00a0https:\/\/doi.org\/10.7326\/M15-2175.","journal-title":"Ann Intern Med"},{"issue":"2","key":"38_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.7326\/M15-1782","volume":"165","author":"M Brasure","year":"2016","unstructured":"Brasure M, Fuchs E, MacDonald R, et al. Psychological and behavioral interventions for managing insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med. 2016;165(2):113\u201324.\u00a0https:\/\/doi.org\/10.7326\/m15-1782.","journal-title":"Ann Intern Med"},{"issue":"2","key":"38_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.7326\/M15-1781","volume":"165","author":"TJ Wilt","year":"2016","unstructured":"Wilt TJ, MacDonald R, Brasure M, et al. Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American college of physicians. Ann Intern Med. 2016;165(2):103\u201312.\u00a0https:\/\/doi.org\/10.7326\/m15-1781.","journal-title":"Ann Intern Med"},{"issue":"2","key":"38_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5664\/jcsm.8988","volume":"17","author":"JD Edinger","year":"2021","unstructured":"Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2021;17(2):263\u201398.\u00a0https:\/\/doi.org\/10.5664\/jcsm.8988..","journal-title":"J Clin Sleep Med"},{"key":"38_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.sleep.2023.01.009","volume":"102","author":"H Scott","year":"2023","unstructured":"Scott H, Cheung JMY, Muench A, et al. Baseline sleep characteristics are associated with gains in sleep duration after cognitive behavioral therapy for insomnia. Sleep Med. 2023;102:199\u2013204.\u00a0https:\/\/doi.org\/10.1016\/j.sleep.2023.01.009.","journal-title":"Sleep Med"},{"issue":"3","key":"38_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.7224\/1537-2073.2019-122","volume":"23","author":"CF Siengsukon","year":"2021","unstructured":"Siengsukon CF, Beck ES Jr, Drerup M. Feasibility and treatment effect of a web-based cognitive behavioral therapy for insomnia program in individuals with multiple sclerosis: a pilot randomized controlled trial. Int J MS Care. 2021;23(3):107\u201313.\u00a0https:\/\/doi.org\/10.7224\/1537-2073.2019-122.","journal-title":"Int J MS Care"},{"key":"38_CR23","doi-asserted-by":"publisher","unstructured":"Granberg RE, Heyer A, Gehrman PR et al. Patient and provider experiences with CBT-I administered in-person or via telemedicine: A randomized non-inferiority trial. Cogent Psychol. 2022;9(1).\u00a0https:\/\/doi.org\/10.1080\/23311908.2022.2038936.","DOI":"10.1080\/23311908.2022.2038936"},{"key":"38_CR24","doi-asserted-by":"publisher","first-page":"e51716","DOI":"10.2196\/51716","volume":"11","author":"WS Chan","year":"2024","unstructured":"Chan WS, Cheng WY, Lok SHC, et al. Assessing the short-term efficacy of digital cognitive behavioral therapy for insomnia with different types of coaching: randomized controlled comparative trial. JMIR Ment Health. 2024;11:e51716.\u00a0https:\/\/doi.org\/10.2196\/51716.","journal-title":"JMIR Ment Health"},{"issue":"1","key":"38_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-022-04411-2","volume":"22","author":"S Liang","year":"2022","unstructured":"Liang S, Mao H, Yang J, et al. Digital cognitive behavior therapy for insomnia improving sleep quality: a real-world study. BMC Psychiatry. 2022;22(1):768.\u00a0https:\/\/doi.org\/10.1186\/s12888-022-04411-2.","journal-title":"BMC Psychiatry"},{"key":"38_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac333","author":"YC Chen","year":"2023","unstructured":"Chen YC, Lu TH, Ku EN, et al. Efficacy of brief behavioural therapy for insomnia in older adults with chronic insomnia: a systematic review and meta-analysis from randomised trials. Age Ageing. 2023;52(1):333. https:\/\/doi.org\/10.1093\/ageing\/afac333.","journal-title":"Age Ageing"},{"issue":"6","key":"38_CR27","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1080\/15402002.2021.1982715","volume":"20","author":"M Kwon","year":"2022","unstructured":"Kwon M, Wang J, Wilding G, Dickerson SS, Dean GE. Brief behavioral treatment for insomnia: a meta-analysis. Behav Sleep Med. 2022;20(6):674\u201394.\u00a0https:\/\/doi.org\/10.1080\/15402002.2021.1982715.","journal-title":"Behav Sleep Med"},{"issue":"11","key":"38_CR28","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1001\/jamapsychiatry.2020.1767","volume":"77","author":"CM Morin","year":"2020","unstructured":"Morin CM, Edinger JD, Beaulieu-Bonneau S, et al. Effectiveness of sequential psychological and medication therapies for insomnia disorder: a randomized clinical trial. JAMA Psychiatry. 2020;77(11):1107\u201315.\u00a0https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.1767.","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"38_CR29","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s11606-018-4390-1","volume":"33","author":"E Koffel","year":"2018","unstructured":"Koffel E, Bramoweth AD, Ulmer CS. Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review. J Gen Intern Med. 2018;33(6):955\u201362.\u00a0https:\/\/doi.org\/10.1007\/s11606-018-4390-1.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"38_CR30","first-page":"241","volume":"103","author":"MA Rhodes","year":"2021","unstructured":"Rhodes MA. Lemborexant (Dayvigo) for the treatment of insomnia. Am Fam Physician. 2021;103(4):241\u20132.","journal-title":"Am Fam Physician"},{"key":"38_CR31","unstructured":"Clinical Trials Arena. Dual orexin receptor antagonists to drive insomnia market across 7MM to $4.1bn in 2023. https:\/\/www.clinicaltrialsarena.com\/analyst-comment\/dora-insomnia-market-7mm\/"},{"issue":"12","key":"38_CR32","doi-asserted-by":"publisher","first-page":"e2349638","DOI":"10.1001\/jamanetworkopen.2023.49638","volume":"6","author":"CM Morin","year":"2023","unstructured":"Morin CM, Chen SJ, Ivers H, et al. Effect of psychological and medication therapies for insomnia on daytime functions: a randomized clinical trial. JAMA Netw Open. 2023;6(12):e2349638.\u00a0https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.49638.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"38_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.smrv.2012.09.005","volume":"17","author":"AN Vgontzas","year":"2013","unstructured":"Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev. 2013;17(4):241\u201354.\u00a0https:\/\/doi.org\/10.1016\/j.smrv.2012.09.005.","journal-title":"Sleep Med Rev"},{"key":"38_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12072498","author":"RM Benca","year":"2023","unstructured":"Benca RM, Bertisch SM, Ahuja A, Mandelbaum R, Krystal AD. Wake up America: national survey of patients\u2019 and physicians\u2019 views and attitudes on insomnia care. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12072498.","journal-title":"J Clin Med"},{"issue":"7\u20138","key":"38_CR35","first-page":"24","volume":"14","author":"KY Jaffer","year":"2017","unstructured":"Jaffer KY, Chang T, Vanle B, et al. Trazodone for insomnia: A systematic review. Innov Clin Neurosci. 2017;14(7\u20138):24\u201334.","journal-title":"Innov Clin Neurosci"},{"issue":"21","key":"38_CR36","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1001\/jama.2020.19224","volume":"324","author":"J Wong","year":"2020","unstructured":"Wong J, Murray Horwitz M, Bertisch SM, Herzig SJ, Buysse DJ, Toh S. Trends in dispensing of zolpidem and low-dose trazodone among commercially insured adults in the united States, 2011\u20132018. JAMA. 2020;324(21):2211\u20133.\u00a0https:\/\/doi.org\/10.1001\/jama.2020.19224.","journal-title":"JAMA"},{"key":"38_CR37","volume-title":"Insomnia: Psychological assessment and management","author":"CM Morin","year":"1993","unstructured":"Morin CM. Insomnia: Psychological assessment and management. New York, NY, US: Guilford Press; 1993."},{"key":"38_CR38","volume-title":"Insomnia: A clinical guide to assessment and treatment","author":"CM Morin","year":"2003","unstructured":"Morin CM, Espie CA. Insomnia: A clinical guide to assessment and treatment. New York, NY, US: Kluwer Academic\/Plenum Publishers; 2003."},{"key":"38_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/med:psych\/9780199339402.001.0001","volume-title":"Overcoming insomnia: a cognitive-behavioral therapy approach, therapist guide, 2nd edition","author":"JD Edinger","year":"2014","unstructured":"Edinger JD, Carney CE. Overcoming insomnia: a cognitive-behavioral therapy approach, therapist guide, 2nd edition. Oxford University Press; 2014."},{"key":"38_CR40","volume-title":"Cognitive behavioral treatment of insomnia: a session-by-session guide","author":"ML Perlis","year":"2005","unstructured":"Perlis ML, Smith MT, Benson-Jungquist C, Posner DA. Cognitive behavioral treatment of insomnia: a session-by-session guide. Springer Nature; 2005."}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44470-025-00038-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44470-025-00038-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44470-025-00038-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:21:06Z","timestamp":1776100866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44470-025-00038-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s44470-025-00038-8","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"13 April 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Buysse is a consultant for BeHealth (2016-current), Eisai, Inc (2019-current), Pear Therapeutics (2019-current), National Cancer Institute (2019-current), Idorsia Pharmaceuticals Ltd (2021-current), Sleep Number (2021-current), Synchronicity Pharma (2025-current); received research support from Sleep Number (2023-2025); is Board President at the Sleep Research Society (2025-2026); and receives compensation from the following intellectual property materials: the Pittsburgh Sleep Quality Index (1989-current), Pittsburgh Sleep Quality Index Addendum for PTSD (PSQI-A) (2005-current), Brief Pittsburgh Sleep Quality Index (B-PSQI) (2021-current), Daytime Insomnia Symptoms Scale (2007-current), Pittsburgh Sleep Diary (1994-current), Insomnia Symptom Questionnaire (2009-current), RU_SATED (copyrights held by University of Pittsburgh) (2021-current), the Consensus Sleep Diary (copyright held by Ryerson University) (2012-current). Dr. Arnedt consulted for Purdue Pharma (2021-2022), Eisai, Inc. (2021-2022), Idorsia Pharmaceuticals Ltd (2022), and received compensation from the following intellectual property materials: telephone-delivered insomnia therapy treatment manuals (copyright held by University of Michigan) (2013-2024). Dr. Fernandez-Mendoza serves on the Society of Behavioral Sleep Medicine\u2019s guideline development expert panel (2023-current) and on the Sleep Research Society\u2019s Board of Directors (2024-current). Dr. Falck-Ytter is a paid consultant for the AASM and an affiliated member of the United States Grading of Recommendations Assessment, Development and Evaluation Network and the Evidence Foundation. Dr. Hyer is employed by the AASM. Ms. Kazmi was formerly employed by the AASM. She was employed by the AASM at the time of her work on this guideline.Dr. Singh serves on the AASM Guideline Advisory Panel; the Hypersomnia Foundation\u2019s medical advisory board (2018-current); has served on the Society of Anesthesia and Sleep Medicine Board of Directors (SASM) (2020-current) and is President-elect of SASM (2024-2026). Dr. Wickwire is a consultant for Nox Health (2023-current) and ResMed Corp. (2022-current); has served as a consultant for Axsome Therapeutics, Eisai, Inc., Ensodata, Idorsia Pharmaceuticals Ltd, Merck Sharp & Dohme Corporation, and Primasun; receives research support from Merck Sharp & Dohme Corporation (2020-current), and ResMed Foundation (2022-2027); owns stock in WellTap (2011-current); and serves on the AASM Board of Directors (2022-current).Dr. Buenaver, Dr. Chang, Dr. Patel, and Dr. Zhou have no relevant conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"56"}}